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HR ¼ 0.947, p ¼ 0.849 and amputation HR ¼ 0.971, p ¼ 0.906). All trends
were lost in diabetic patients alone (n ¼ 149, 69% of group).
Conclusion: In this the largest series of combined angioplasty in the
literature there was no advantage in opening up all the tibial vessels with
angioplasty if the angiosome directly supplying the ischaemic tissue could
be opened. The angiosome model does not appear valid, however, in
diabetic patients.
Long Term Risk for Peripheral Arterial Disease Patients is Higher
Among Men
B. Sigvant
Dept. of Surgery, Central Hospital in Karlstad, Sweden
Introduction: The introduction of modern cardiovascular risk preventive
therapy and new endovascular treatment options may have inﬂuenced the
long term mortality and morbidity in patients with peripheral arterial dis-
ease (PAD). The aim of this study was to determine long-term survival and
incidence of leg revascularizations in subjects with PAD with special focus
on gender differences.
Methods: A cohort study was started 2004 by randomly selecting 8000
subjects, aged 59e89 years, from the population. A total of 5080 subjects
participated and underwent ankle brachial index measurements (ABI). Data
was also collected for risk factors and concomitant diseases. The cohort
was re-examined 2015 covering data from national governmental registries
on survival and surgical interventions for PAD.
Results: The point-prevalence of PAD in 2004 was 11 % (95% CI, 9e13)
for subjects having only asymptomatic PAD (APAD), 7% (6.5 e7) for
intermittent claudication (IC) and 1.2 % (1 e1.5) for those with severe limb
ischemia(SLI). Among the 4926 subjects who were available for follow up at
10 years the mortality rates were 50% for APAD, 59% for IC and 72% for SLI.
Subjects without PAD had a rate of 24%. Mortality was higher among men
(age adjusted 35.9% 95% CI: 34.2e37.6) than women (26.1% 95% CI: 24.7e
27.6) likewise in PAD subjects with diabetes mellitus (68% vs. 52% without,
p < 0.001). Factors signiﬁcantly related to increased mortality were for
men and women, respectively; SLI (HR 1.87 and 1.87), congestive heart
failure (HR 1.69 vs. 2.44), renal failure (HR 1.4. vs. 2.2) and diabetes (HR
1.51 vs. 1.65). Fifty one subjects underwent revascularization because of
chronic leg ischemia in the cohort during the ten years. In the reference
group the rate was 0.4%, while it was 1.9 % of APAD subjects, 5.8 % of the
IC and 6.2% of the SLI group.
Conclusion: The mortality is still high in patients with PAD, and half of
patients with APAD are dead within 10 years which is comparable with IC
patients. The mortality is higher in men than in women. In a population
based cohort like this, very few patients were revascularized, and surpris-
ingly few patients with IC and SLI are offered vascular surgery. Overall,
more focus on mortality in PAD is needed and there is still a need for in-
formation about vascular surgery to GP’s ofﬁces and awareness among PAD
subjects.
Oral Prostacycline Analog and Clopidogrel Combination provides
Early Maturation and Long-term Survival after Arteriovenous
Fistula Creation: A Randomized Controlled Study
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Introduction: Vascular access is used as a lifeline for hemodialysis in pa-
tients with end stage renal disease failure (ESRD). Failure of arteriovenous
ﬁstula (AVF) maturation is still high. The purpose of this study was to
research the effects of clopidogrel in combination with oral iloprost, a
synthetic analog of prostacyclin PGI2.
Methods: Ninety-six diabetic ESRD patients were divided into two
groups. In the ﬁrst group (Group 1, N ¼ 50), clopidogrel (75 mg daily dose)
and an oral prostacycline analog (200 mg daily dose) were administered. In
the second group (Group 2, N ¼ 46), placebo was given. All patients were
taking study medication 7e10 days prior to surgery. A Doppler ultraso-
nographic (USG) examination was performed for measurement of arterialand venous diameters, and peak systolic velocity of arterial ﬂow based on
subsequent ﬁstula adequacy. Autogenous AVFs were constructed in fore-
arm as distally as possible in all patients. Both groups were followed-up for
a year.
Results: In the placebo group, early AVF thrombosis was detected in
two patients (4.3%). AVF maturation failure was noted in 14 patients
(30.4%) in placebo group and in four patients (8%) in clopidogrel plus oral
prostacycline analog group in the early post-operative period (P ¼ 0.001).
The mean maturation time was 38  6.5 and 53  12.8 days in study and
placebo groups, respectively (P ¼ 0.023). The mean blood ﬂow was
352  94 mL/min in placebo group and 604  125 mL/min in study group
(P ¼ 0.001). The arterial end diastolic velocity was 116  14 cm/s in study
group and 72  21 cm/s in placebo group (P ¼ 0.036) 1 year after the
surgery.
Conclusion: Our data indicated that clopidogrel and oral prostacycline
analog as a potent arterial dilator seems to be effective and safe for the
prevention of primary AVF failure in hemodialysis patients and decreased
acute and chronic thrombotic events of AVFs.
Radiation Dose of Cone Beam Computed Tomography and
Computed Tomography during EVAR: A Patient and Phantom
Study
P. Törnqvist
Skane Vascular Center, Malmo, Sweden
Introduction: The use Cone Beam Computed Tomography (CBCT) enables
the acquisition of 3D images intra-operative. This advantage might reduce
the need of early Computed Tomography Angiography (CTA) follow up (FU)
since technical success is improved. It is however known the CBCT adds a
considerable amount of radiation to the intervention. This study is quan-
tifying the CBCT radiation in comparison to conventional 1 month FU CTA in
order to increase the awareness of the operator in the intra-operative
setting.
Methods: Radiation dose of CBCT (DynaCT, Siemens) and FU CTA of 30
patients was prospectively studied. The CBCT consisted of two different
protocols and was compared with two different CT scanners (Somatom 16
and Flash, Siemens). The FU CTA included three phases. Conversion factors
were used to calculate effective dose in order to be able to compare CBCT
and FU CTA radiation dose. An anthropomorphic phantom was used as
comparison and a TG200 phantom enabled the direct comparison of the
accumulated radiation, without the need of conversion factors.
Results: Mean age was 73 years and average BMI was 27,5. CBCT
radiation contributed with a mean DAP of 66.0 Gycm22 (37,1 e94,4). The
3 phase FU CTA had a mean DLP of 948.7 mGycm (421 e1422). A CBCT of
5 seconds corresponded to one third of that of a 16 slice FU CTA. An 8
second spin was 87% of that of a 128 slice FU CTA. Accumulated radiation
from the CBCT ranged from 44% to 99% in comparison to the complete
FU CTA.
Conclusion: CBCT adds a considerably amount of radiation to the pa-
tient during an EVAR procedure. The comparison between CBCT and CT
depends on what type of CBCT protocol and how efﬁcient the CT scanner is.
This study showed that performing an intra-operative 8 second CBCT is
equivalent to a complete FU CTA, consisting of three CT scans. Further
optimization of CBCT protocol in regard of image quality and intra-opera-
tive results ought to be investigated.
Role of Hybrid Procedures in the Treatment of Iliac Femoral
Occlusive Disease
G. Zenunaj
Unit of Vascular and Endovascular Surgery, Italy
Introduction: At aorta-iliac district for occlusive disease the ﬁrst choice
have became endovascular procedures because offer excellent results in
terms of patency, low mortality and morbidity rates. Stenosis/occlusion to
the femoral artery may reduce the patency and the technical success rate
of the endovascular procedures. In these cases a hybrid approach with
femoral endarterectomy and iliac stenting may be considered. We
Abstracts 401evaluated the results in patients treated by hybrid and traditional surgery
in order to establish if these procedures could be considered as the ﬁrst
choice.
Methods: We performed a retrospective study analyzing a frame time
of 13 years in order to identify patients with iliac femoral atheromatous
disease (TASC II C/D). Primary end points have been considered the pri-
mary patency rate, limb savage and survival rate. Secondary end points
such as secondary assisted patency, re-interventions and complications
rate.
Results: We identiﬁed 178 limbs in 168 patients (100 vs. 78 limbs
treated respectively with Open and Hybrid approach). In the Hybrid group
86% of the patients were classiﬁed as ASA III/IV vs. 31% in Open group.
Median age was 68 vs. 75 respectively per open and hybrid group. Indi-
cation for hybrid procedures was given in 93 limbs but after an accurate
pre-operative study with Angio-CT scan we excluded 15 limbs due heavy
calciﬁcation in 13 patients classiﬁed as ASA III/IV that underwent to extra-
anatomic repair. The technical success was 91.7% vs.100% (Open versus
Hybrid). Primary patency in Open vs. Hybrid group at 1, 5 years was
respectively 98%,99% vs. 7.5%,96.1%, assisted patency at 1, 5 years 99%,
98% vs. 98.7%, 97.5%, limb salvage at 1, 5 years 99%,98% vs. 96%,93.5%.
30 days mortality and at 1, 5 years were 5.6% e 28.4% vs. 1.2% e 25.6%
Open vs. Hybrid group. Similar post-operative complications rate (6%) were
observed in both groups, but 8.1% of open group needed admission
intensive unit care.
Conclusion: Hybrid procedures offered good results in terms of patency
and limb salvage rate and with a low 30 mortality in patients classiﬁed at
high risk for surgery. Similar survival rates between the 2 groups despite
the high co-morbidities and older age that characterized the Hybrid group.
Considering the good results the hybrid procedures could be considered as
the ﬁrst choice, but in some patients the anatomic arterial features remain
the main limitation that still need traditional repair.
Comparison between Aorto-bifemoral Bypass and Aorto-iliac
Kissing Stent in Patients with Complex Aorto-iliac Obstructive
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Introduction: To retrospectively compare early and late results of aorto-
bifemoral bypass and endovascular recanalization with the kissing stent
technique in the management of TASC II C and D lesions in the aorto-iliac
district in a multicentre study.
Methods: From January 2006 to December 2013, 293 open and endo-
vascular interventions for TASC-II class C and D aorto-iliac obstructive le-
sions were performed at three Italian teaching hospitals. In 210 patients
the intervention was performed for aortic and bilateral iliac involvement:
an aorto-bifemoral bypass was performed in 82 patients (Group 1) while in
the remaining 128 an endovascular recanalization with the kissing stent
technique (Group 2). Early results in the two groups were compared with
c2 test. Follow up results were analyzed with Kaplan-Meyer curves and
compared with log rank test.
Results: There were no differences between the two groups in terms of
demographic data, comorbidities, or risk factors for atherosclerosis, except
for a higher percentage of females and of diabetic patients in group 2.
Critical limb ischemia was present in 29 patients in group 1 (35.5%) and in
31 patients in group 2 (24%, p ¼ 0.07). Technical success in group 2 was
98.5%; two patients required immediate conversion to open surgery for
iliac rupture. There was one peri-operative death in group 1 (mortality rate
1.2%, p ¼ 0.2 in comparison with group 2). Four peri-operative thromboses
occurred; two in group 1 and two in group 2 (in one case requiring con-
version to open surgical intervention) and no amputations at 30 days were
recorded. Post-operative local and systemic complications occurred in 20
patients in group 1 (24%) and in 13 patients in group 2 (10% p ¼ 0.006).
Mean duration of follow up was 39 months (range 1 e108 months). Sur-
vival rates at 6 years were 65% (SE 0.07) in group 1 and 82% (SE 0.05) ingroup 2 (p¼ 0.07). At the same time interval, primary, assisted primary and
secondary patency rates were similar; re-intervention rates were 6% in
group 1 (SE 0.05) and 11% in group 2 (SE 0.04; p ¼ 0.2).
Conclusion: Endovascular repair of complex aorto-iliac lesions with the
kissing stent technique, in the multicentre experience, provided similar
satisfactory early and late results to those obtained with open surgery,
however with a lower rate of peri-operative complications and a trend
towards better long-term survival.
Long Term Outcomes of Common Femoral Artery Endovascular
Repair
A. Kaladji, P.-A. Vent, P. Chaillou, A. Costargent, T. Quillard, Y. Gouefﬁc
CHU Nantes, France
Introduction: The common femoral artery (CFA) is an unusual location for
endovascular repair (ER). However, previous reports have showed that it
was a safe technique with acceptable clinical outcome at 1 year. The aim of
this manuscript is to report 5 year outcomes after primary stenting of the
CFA and its bifurcation for occlusive disease.
Methods: Between 2006 and 2008, 36 consecutive patients (mean age
67.9 years, range 51e92) (40 limbs) underwent primary stenting for CFA
lesions. Patients were followed up systematically within a prospectively
maintained database over 5 years. Follow up included clinical examination,
duplex scan and biplane x-ray at 1, 6, and 12 months and yearly thereafter.
Data of 2 patients are lacking because they are waiting for their duplex
scan results.
Results: Indications for endovascular repair of the CFA included 25
patients (70%) for claudication and 11 patients (30%) for critical limb
ischemia. Forty-three stents were implanted. The mean follow up was 64
months (range 9-e108 months). Two patients were lost of follow up. The
mortality rate at 5 years was 38%. At 1 and 5 years, primary sustained
clinical improvements were 80% and 75% respectively. In-stent restenosis
rate was 22%. Freedom from target lesion revascularisation was 85% and
76% at 1 and 5 years, respectively. One stent fracture was noted in the ﬁrst
year follow up and no other stent fracture was noted during the reminder
of the study. No risk factors (age, sex, diabetes, stage of peripheral artery
disease, types of CFA lesions, types of stents) were signiﬁcantly associated
with in-stent re-stenosis or stent fracture at 5 years.
Conclusion: Endovascular repair of CFA and its bifurcation seems to
provide a sustained clinical and morphological results at long-term. The fear
of stent fracture and local complications due to the hip mobility are no
longer relevant.
Trends and Outcomes of Carotid Endarterectomy and Carotid
Stenting in Germany Between 2003 and 2013 -e Results from the
German Mandatory National Quality Assurance Registry
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Introduction: Since 2003 carotid endarterectomies (CEA) and since 2012
carotid artery stenting procedures (CAS) are documented in a mandatory
nationwide quality assurance registry. This study analyses management
trends in patients treated by CEA or CAS in Germany over a 11 year period.
Methods: Annual reports of the “Bundesgeschäftstelle Qualitätssicher-
ung (BQS)” and the “Institute for Applied Quality Improvement and
Research in Health Care (AQUA)” from 2003 to 2013 were reviewed. Trends
in patients characteristics, peri-procedural variables and outcomes were
statistically analysed by the Cochran-Armitage-Trend-Test. Descriptive data
are given as mean or median.
Results: 1. 282.603 CEAs and 11.993 CAS procedures were performed
(male 68.3%). The proportion of patients >80 years increased signiﬁcantly
from 10.9% to 15.7% (p < 0.001). Indication groups were: asymptomatic
(mean rate: CEA: 52.7%, CAS: 47.3%), symptomatic (CEA: 34.7%, CAS:
25.9%) and special indications (e.g. emergency procedures, recurrent ste-
nosis, carotid aneurysms (CEA: 12.6%, CAS: 26.5%).
